Long-Acting Agonists in the Management of Stable Chronic Obstructive Pulmonary Disease

By Cazzola M.  

Drugs, Vol. 60, Iss. 2, 2000-08 ,pp. : 307-320

Adis International

Access to resources Recommend Favorite

Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease

By Matera Maria Gabriella   Rogliani Paola   Cazzola Mario  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 961-977

Informa Healthcare

Access to resources Recommend Favorite

Indacaterol: a new long-acting β₂-agonist in the management of chronic obstructive pulmonary disease

By Steiropoulos Paschalis   Papanas Nikolaos   Nena Evangelia   Bouros Demosthenes  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 7, 2012-05 ,pp. : 1015-1029

Informa Healthcare

Access to resources Recommend Favorite

Ultra long-acting β₂-agonists in development for asthma and chronic obstructive pulmonary disease

By Cazzola Mario   Matera Maria Gabriella   Lötvall Jan  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 7, 2005-07 ,pp. : 775-783

Informa Healthcare

Access to resources Recommend Favorite

Combination Therapy of Inhaled Corticosteroids and Long-Acting &bgr;2- Adrenergics In Management of Patients with Chronic Obstructive Pulmonary Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 28, 2004-11 ,pp. : 3547-3560

Bentham Science Publishers

Access to resources Recommend Favorite